Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia.
作者信息
Jones Carol D, Arai Sally, Lowsky Robert, Tyan Dolly B, Zehnder James L, Miklos David B
出版信息
Br J Haematol. 2010 Sep;150(5):637-9. doi: 10.1111/j.1365-2141.2010.08252.x. Epub 2010 Jun 7.
Abstract
摘要
相似文献
1
Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia.异基因移植30天后供体T细胞完全植入可预测高危慢性淋巴细胞白血病的分子缓解。
Br J Haematol. 2010 Sep;150(5):637-9. doi: 10.1111/j.1365-2141.2010.08252.x. Epub 2010 Jun 7.
2
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?瑞典异基因造血干细胞移植治疗慢性淋巴细胞白血病：移植后 3 个月供者 T 细胞嵌合状态能否预测生存？
Leuk Lymphoma. 2012 Sep;53(9):1699-705. doi: 10.3109/10428194.2012.666661. Epub 2012 Mar 16.
3
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.减低强度预处理和异基因干细胞移植后慢性淋巴细胞白血病移植物抗白血病效应的证据：德国移植协作研究组
J Clin Oncol. 2003 Jul 15;21(14):2747-53. doi: 10.1200/JCO.2003.12.011.
4
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia.异体造血干细胞移植后基于风险分层的过继性细胞治疗晚期慢性淋巴细胞白血病。
Br J Haematol. 2013 Mar;160(5):640-8. doi: 10.1111/bjh.12197. Epub 2013 Jan 7.
5
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality.非清髓性异基因造血移植作为惰性淋巴瘤的过继性免疫治疗：毒性、急性移植物抗宿主病及治疗相关死亡率发生率低。
Blood. 2001 Dec 15;98(13):3595-9. doi: 10.1182/blood.v98.13.3595.
6
Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort.异基因造血干细胞移植治疗慢性淋巴细胞白血病：20 年队列研究结果。
Br J Haematol. 2012 Jul;158(2):174-185. doi: 10.1111/j.1365-2141.2012.09170.x. Epub 2012 May 29.
7
Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.对晚期血液系统恶性肿瘤患者进行非清髓性预处理的异基因造血细胞移植。
Cytotherapy. 2001;3(4):253-60. doi: 10.1080/146532401317070880.
8
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia.快速完全供者淋巴嵌合和移植物抗白血病效应对于早期控制慢性淋巴细胞白血病非常重要。
Exp Hematol. 2013 Sep;41(9):772-8. doi: 10.1016/j.exphem.2013.04.015. Epub 2013 May 18.
9
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.采用减低强度预处理的异基因干细胞移植治疗慢性淋巴细胞白血病后的治疗相关死亡率及移植物抗白血病活性
Leukemia. 2003 May;17(5):841-8. doi: 10.1038/sj.leu.2402905.
10
Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning.与低强度非清髓性预处理相比，含烷化剂化疗的减低强度预处理方案并未改变慢性淋巴细胞白血病患者异基因造血细胞移植后的生存结局。
J Cancer Res Clin Oncol. 2019 Nov;145(11):2823-2834. doi: 10.1007/s00432-019-03014-x. Epub 2019 Aug 29.
引用本文的文献
1
The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review.异基因造血细胞移植在慢性淋巴细胞白血病中的作用：综述
Front Oncol. 2023 Jan 18;12:1105779. doi: 10.3389/fonc.2022.1105779. eCollection 2022.
2
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.接受异基因干细胞移植治疗慢性淋巴细胞白血病患者的长期随访：混合性T细胞嵌合与高复发风险及较差生存率相关。
Br J Haematol. 2017 May;177(4):567-577. doi: 10.1111/bjh.14596. Epub 2017 Mar 14.
3
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT.依鲁替尼在异基因造血干细胞移植后复发的慢性淋巴细胞白血病患者中的疗效和耐受性。
Blood. 2016 Dec 22;128(25):2899-2908. doi: 10.1182/blood-2016-06-715284. Epub 2016 Nov 1.
4
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia.快速完全供者淋巴嵌合和移植物抗白血病效应对于早期控制慢性淋巴细胞白血病非常重要。
Exp Hematol. 2013 Sep;41(9):772-8. doi: 10.1016/j.exphem.2013.04.015. Epub 2013 May 18.
5
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.异基因移植后预防性使用利妥昔单抗可降低 B 细胞同种异体免疫反应，慢性移植物抗宿主病发生率低。
Blood. 2012 Jun 21;119(25):6145-54. doi: 10.1182/blood-2011-12-395970. Epub 2012 May 4.
6
Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction.造血细胞移植中的转化研究：以血液系统恶性肿瘤治疗为诱导耐受的踏脚石。
Semin Immunol. 2011 Aug;23(4):273-81. doi: 10.1016/j.smim.2011.05.001. Epub 2011 Jun 25.
本文引用的文献
1
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors.低移植物抗宿主病风险的TLI和ATG预处理在来自相关和无关供体的异基因造血细胞移植后仍保留抗肿瘤反应。
Blood. 2009 Jul 30;114(5):1099-109. doi: 10.1182/blood-2009-03-211441. Epub 2009 May 7.
2
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia: early assessment can predict long-term outcome after reduced intensity allogeneic transplantation.复发慢性淋巴细胞白血病微小残留病的定性和定量聚合酶链反应监测：早期评估可预测减低强度异基因移植后的长期预后。
Haematologica. 2009 May;94(5):654-62. doi: 10.3324/haematol.2008.000273. Epub 2009 Apr 18.
3
Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse.儿童急性淋巴细胞白血病的异基因移植：移植前微小残留病/嵌合体监测以及旨在预防复发的新型化疗、分子和免疫方法的新作用。
Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):62-71. doi: 10.1016/j.bbmt.2008.11.009.
4
Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia: results from the GCLLSG CLL3X trial.定量微小残留病监测可识别慢性淋巴细胞白血病异基因干细胞移植后的不同移植物抗白血病反应模式：来自GCLLSG CLL3X试验的结果。
Leukemia. 2008 Jul;22(7):1377-86. doi: 10.1038/leu.2008.96. Epub 2008 Apr 17.
5
Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion.复发慢性粒细胞白血病患者T细胞和树突状细胞嵌合状态的动态变化及其对供体淋巴细胞输注后同种异体反应性诱导的影响。
Bone Marrow Transplant. 2007 Sep;40(6):585-92. doi: 10.1038/sj.bmt.1705777. Epub 2007 Jul 16.
6
Protective conditioning for acute graft-versus-host disease.急性移植物抗宿主病的保护性预处理
N Engl J Med. 2005 Sep 29;353(13):1321-31. doi: 10.1056/NEJMoa050642.
7
Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.减低剂量预处理（RIC）异基因移植后的嵌合状态及微小残留病监测
Leukemia. 2002 Aug;16(8):1423-31. doi: 10.1038/sj.leu.2402550.
8
Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma.用于多发性骨髓瘤微小残留病定量评估的免疫球蛋白重排实时聚合酶链反应
Biol Blood Marrow Transplant. 2000;6(3):241-53. doi: 10.1016/s1083-8791(00)70006-1.
Zotero 插件